Health Plans Embrace Biosimilars to Reduce Costs and Improve Patient Access | AMCP Nexus 2024

News
Article

How health plans are implementing strategies to leverage biosimilars to lower costs for both payers and patients.

Health plans are modifying their benefit designs to take advantage of the cost savings offered by biosimilars, according to Javier Gonzalez, Pharm.D., chief growth and commercial officer of Abarca.

“We've been working with our clients to develop strategies and initiatives to take advantage of the biosimilars, to protect the affordability and accessibility of very important therapies for high risk, high cost specialty conditions,” Gonzalez said.

Abarca is a health IT company and pharmacy benefit manager. Gonzalez co-lead the session, ‘Are Patients Getting a Fair Share of the Value of Biosimilars?’ today at AMCP Nexus, held at the MGM Grand in Las Vegas.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.